This is a listing of Requests for Applications (RFA), Program Announcements (PA), and Notices specific to the group's key programs.
Standard submission dates apply for all listings, unless otherwise noted.
Guidance For Investigators Planning to Submit a Program Project Grant (P01)
NCI SBIR Contract Solicitation Digital Tools to Integrate Cancer Prevention Within Primary Care (https://sbir.cancer.gov/small-business-funding/contracts/current-solicitation/453) This solicitation will be open to applications through November 4th.
Notice: Internet links not permitted in NIH Grant Applications
Information about the funding opportunity announcements that align with the efforts of the Cancer MoonshotSM can be found here: https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding.
| Title | Announcement # | Expiration Date | Activity Code | Contact |
|---|---|---|---|---|
| Administrative Supplement for Research on Dietary Supplements | PA-20-227 (Admin Supp-Clinical Trial Not Allowed) | 04/16/2023 | Sharon Ross, Ph.D., M.P.H. | |
| Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional) | PAR-22-114 | 01/24/2025 | Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H. | |
| Assay Validation of High Quality Markers for Clinical Studies in Cancer | PAR-20-313 (UH2/UH3 Clinical Trial Not Allowed) | 10/11/2023 | UH2, UH3 | Lynn Sorbara, Ph.D. |
| Assay Validation of High Quality Markers for Clinical Studies in Cancer | PAR-20-314 (UH3 Clinical Trials Not Allowed) | 10/11/2023 | UH3 | Lynn Sorbara, Ph.D. |
| Basic Research in Cancer Health Disparities | PAR-21-322 (R01 Clinical Trial Not Allowed) | 09/08/2024 | R01 | Asad Umar, D.V.M., Ph.D. |
| Basic Research in Cancer Health Disparities | PAR-21-324 (R03 Clinical Trial Not Allowed) | 09/08/2024 | R03 | Asad Umar, D.V.M., Ph.D. |
| Basic Research in Cancer Health Disparities | PAR-21-323 (R21 Clinical Trial Not Allowed) | 09/08/2024 | R21 | Asad Umar, D.V.M., Ph.D. |
| Biology of Bladder Cancer | PAR-22-218 (R01 Clinical Trial Optional) | 09/08/2025 | R01 | Chen S. Suen, R.Ph., Ph.D. |
| Biology of Bladder Cancer | PAR-22-219 (R21 Clinical Trial Optional) | 09/08/2025 | R21 | Chen S. Suen, R.Ph., Ph.D. |
| Cancer Prevention and Control Clinical Trials Grant Program | PAR-21-035 (R01 Clinical Trial Required) | 01/08/2024 | R01 | Brandy Heckman-Stoddard, Ph.D., M.P.H. |
| Cancer Prevention and Control Clinical Trials Planning Grant Program | PAR-22-173 (R34 Clinical Trials Optional) | 05/08/2025 | R34 | Brandy Heckman-Stoddard, Ph.D., M.P.H. |
| Cancer Prevention and Control Clinical Trials Planning Grant Program | PAR-22-174 (U34 Clinical Trials Optional) | 05/08/2025 | U34 | Brandy Heckman-Stoddard, Ph.D., M.P.H. |
| Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research | PAR-22-099 (R01 Clinical Trial Optional) | 05/08/2025 | R01 | Richard Mazurchuk, Ph.D. |
| Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies | PAR-21-329 (R01 Clinical Trial Optional) | 11/06/2024 | R01 | Alexis Bakos, Ph.D., M.P.H., R.N. |
| Clinical Sites for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network | RFA-CA-22-051 (UG1 Clinical Trial Required) | 12/29/2022 | UG1 | Vikrant V. Sahasrabuddhe, M.B.B.S., Dr.P.H. |
| Co-infection and Cancer | PAR-20-062 (R01 Clinical Trial Not Allowed) | 01/08/2023 | R01 | Jo Ann Rinaudo, Ph.D. |
| Consortium on Translational Research in Early Detection of Liver Cancer: Data Management and Coordinating Center | RFA-CA-22-032 (U24 Clinical Trial Not Allowed) | 11/08/2022 | U24 | Guillermo Marquez, Ph.D. |
| Consortium on Translational Research in Early Detection of Liver Cancer: Translational Research Centers | RFA-CA-22-031 (U01 Clinical Trial Optional) | 11/08/2022 | U01 | Matthew Young, Ph.D. |
| Emergency Awards: HEAL Initiative-Early-Stage Discovery of New Pain and Opioid Use Disorder Targets Within the Understudied Druggable Proteome | RFA-TR-22-011 (R21 Clinical Trial Not Allowed) | 05/23/2023 | R21 | |
| Emergency Awards: HEAL Initiative- New Innovator Award | RFA-TR-22-013 (DP2 Clinical Trial Not Allowed) | 05/23/2023 | DP2 | Rachel Altshuler, Ph.D. |
| HEAL Initiative: Development and Validation of Non-Rodent Mammalian Models of Pain | RFA-NS-22-070 (R01 Clinical Trial Not Allowed) | 03/07/2024 | R01 | |
| HEAL Initiative: Discovery and Functional Evaluation of Human Pain-associated Genes and Cells | RFA-NS-22-018 (U19 Clinical Trial Not Allowed) | 03/10/2023 | U19 | Rachel Altshuler, Ph.D. |
| HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment | RFA-NS-22-034 (R01 Clinical Trial Not Allowed) | 12/07/2024 | R01 | Rachel Altshuler, Ph.D. |
| HEAL Initiative: Discovery of Biomarkers and Biomarker Signatures to Facilitate Clinical Trials for Pain Therapeutics (UG3/UH3 Clinical Trial Optional) | RFA-NS-22-050 | 02/24/2023 | UG3, UH3 | Alexis Bakos, Ph.D., M.P.H., R.N. |
| HEAL Initiative: Human Pain-associated Genes and Cells Data Coordination and Integration Center | RFA-NS-22-021 (U24 Clinical Trial Not Allowed) | 10/12/2022 | U24 | Rachel Altshuler, Ph.D. |
| HEAL Initiative: Interdisciplinary Team Science to Uncover the Mechanisms of Pain Relief by Medical Devices | RFA-NS-23-003 (RM1 Clinical Trial Optional) | 06/10/2025 | RM1 | Alexis Bakos, Ph.D., M.P.H., R.N. |
| HEAL Initiative Notice of Special Interest (NOSI): Development and Validation of Pain-Related Models and Endpoints to Facilitate Non-Addictive Analgesic Discovery | NOT-NS-22-095 | 06/25/2025 | Rachel Altshuler, Ph.D. | |
| HEAL Initiative: Preventing Opioid Misuse and Co-Occurring Conditions by Intervening on Social Determinants | RFA-DA-23-051 (R01 - Clinical Trials Optional) | 02/03/2023 | R01 | Alexis Bakos, Ph.D., M.P.H., R.N. |
| HEAL Initiative: Prevention and Management of Chronic Pain in Rural Populations (UG3/UH3, Clinical Trials Required) | RFA-NR-23-001 | 11/22/2022 | Alexis Bakos, Ph.D., M.P.H., R.N. | |
| HEAL Initiative: Team Research for Initial Translational Efforts in Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] | RFA-NS-22-052 (U19 Clinical Trial Not Allowed) | 10/11/2023 | U19 | Rachel Altshuler, Ph.D. |
| HEAL Initiative: Translational Development of Diagnostic and Therapeutic Devices | RFA-EB-22-002 (R18 Clinical Trial Not Allowed) | 06/18/2025 | R18 | Rachel Altshuler, Ph.D. |
| Health Care Models for Persons with Multiple Chronic Conditions from Populations that Experience Health Disparities: Advancing Health Care towards Health Equity | PAR-22-092 (R01 - Clinical Trials Optional) | 09/08/2024 | R01 | Ellen Richmond, M.S., G.N.P.-B.C. |
| Mechanisms that Impact Cancer Risk after Bariatric Surgery | PAR-21-332 (R21 Clinical Trial Not Allowed) | 09/08/2024 | R21 | Edward Sauter, M.D., Ph.D. |
| Mechanisms that Impact Cancer Risk after Bariatric Surgery | PAR-21-331 (R01 Clinical Trial Optional) | 09/08/2024 | R01 | Edward Sauter, M.D., Ph.D. |
| Music and Health: Understanding And Developing Music Medicine | PAR-21-099 (R21 Clinical Trial Optional) | 02/17/2023 | R21 | Alexis Bakos, Ph.D., M.P.H., R.N. |
| Music and Health: Understanding And Developing Music Medicine | PAR-21-100 (R01 Clinical Trial Optional) | 02/06/2023 | R01 | Alexis Bakos, Ph.D., M.P.H., R.N. |
| NCI Cancer Moonshot Scholars Diversity Program (CMSDP) | RFA-CA-22-050 (R01 Clinical Trial Optional) | 02/07/2024 | R01 | Brandy Heckman-Stoddard, Ph.D., M.P.H. |
| NCI Clinical and Translational Exploratory/Developmental Studies | PAR-22-216 (R21 Clinical Trial Optional) | 07/02/2025 | R21 | Marjorie Perloff, M.D. |
| NIH HEAL Initiative: Coordinated Approaches to Pain Care in Health Care Systems | RFA-NS-22-053 (UG3/UH3 - Clinical Trial Optional) | 11/05/2022 | UG3, UH3 | Alexis Bakos, Ph.D., M.P.H., R.N. |
| NIH Research Project Grant | PA-20-185 (Parent R01 Clinical Trial Not Allowed) | 05/08/2023 | R01 | |
| Notice of Correction to Application Types Allowed for PAR-20-053, Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection | NOT-CA-20-067 (R01 Clinical Trial Not Allowed) | 01/08/2023 | R01 | Matthew Young, Ph.D. |
| Notice of Correction to PAR-21-035, Cancer Prevention and Control Clinical Trials Grant Program | NOT-CA-22-012 (R01 Clinical Trials Required) | 01/08/2024 | R01 | Brandy Heckman-Stoddard, Ph.D., M.P.H. |
| Notice of Intent to Publish a Funding Opportunity Announcement for Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Centers | NOT-CA-22-120 (U54 Clinical Trial Not Allowed) | 11/14/2022 | U54 | Shizuko Sei, M.D. |
| Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Initiative: Prevention and Management of Chronic Pain in Rural Populations (UG3/UH3, Clinical Trials Required) | NOT-NR-22-015 | 08/01/2023 | UG3, UH3 | Alexis Bakos, Ph.D., M.P.H., R.N. |
| Notice of Intent to Publish a Funding Opportunity Announcement for NCI Cancer Screening Research Network: ACCrual, Enrollment, and Screening Sites (ACCESS) Hub | NOT-CA-22-129 (UG1 Clinical Trial Required) | 02/06/2023 | UG1 | Paul Pinsky, Ph.D. |
| Notice of Intent to Publish a Funding Opportunity Announcement for NCI Cancer Screening Research Network: Coordinating and Communication Center | NOT-CA-22-131 (UG1 Clinical Trial Required) | 02/06/2023 | UG1 | Paul Pinsky, Ph.D. |
| Notice of Intent to Publish a Funding Opportunity Announcement for NCI Cancer Screening Research Network: Statistics and Data Management Center | NOT-CA-22-130 (UG1 Clinical Trial Required) | 02/06/2023 | UG1 | Paul Pinsky, Ph.D. |
| Notice of NCI Participation in PAR-22-064, Patient-Clinician Relationship: Improving Health Outcomes in Populations that Experience Health Care Disparities | NOT-CA-22-048 (R01 Clinical Trial Optional) | 01/08/2025 | R01 | Diane St Germain, R.N., M.S., C.R.N.P. |
| Notice of Special Interest: Administrative Supplements for Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed) | NOT-OD-22-202 | 04/16/2025 | Nancy J. Emenaker, Ph.D., R.D.N., L.D., F.A.N.D. | |
| Notice of Special Interest: Advancing the Science of Geriatric Palliative Care | NOT-AG-20-041 | 09/08/2023 | Diane St Germain, R.N., M.S., C.R.N.P. | |
| Notice of Special Interest: Development of Swallowable Smart Pills or Devices for Precision Nutrition, Microbiome and Digestive Disease Applications | NOT-DK-20-001 | 01/08/2023 | ||
| Notice of Special Interest: National Cancer Institute Administrative Supplement Opportunity for Strategies to Optimize Recruitment and Retention of Cancer Prevention and Symptom Management Clinical Trial Participants | NOT-CA-21-070 | 05/16/2023 | Ellen Richmond, M.S., G.N.P.-B.C. | |
| Notice of Special Interest (NOSI): Basic Mechanisms of Cannabis and Cannabinoid Action in Cancer | NOT-CA-22-085 | 05/08/2027 | Sharon Ross, Ph.D., M.P.H. | |
| Notice of Special Interest (NOSI): Biology of Lung and Head and Neck Preneoplasia | NOT-CA-21-057 | 05/08/2023 | Malgorzata (Margaret) Wojtowicz, M.D. | |
| Notice of Special Interest (NOSI): Dietary, Physical Activity, Sedentary Behavior and Sleep Assessment Methodologies Among Infants and Young Children (Birth to 5 years) through Adults | NOT-CA-21-108 | 05/08/2023 | ||
| Notice of Special Interest (NOSI): Encourage Eligible NIH HEAL Initiative Awardees to Apply for Administrative Supplements to Support Career Enhancement Related to Clinical Research on Pain | NOT-NS-22-087 | 02/16/2024 | ||
| Notice of Special Interest (NOSI): HEAL Initiative: Clinical Translation of Diagnostic and Therapeutic Devices via Blueprint MedTech | NOT-NS-23-002 | 06/21/2024 | ||
| Notice of Special Interest (NOSI): Improving Outcomes in Cancer Treatment-Related Cardiotoxicity | NOT-CA-22-001 | 11/06/2024 | ||
| Notice of Special Interest (NOSI): Leveraging Real-World Imaging Data for Artificial Intelligence-based Modeling and Early Detection of Abdominal Cancers | NOT-CA-21-028 | 01/08/2024 | Natalie Abrams, Ph.D. | |
| Notice of Special Interest (NOSI): Single-Cell Proteomics for Interrogating Premalignant and Early Malignant Lesions | NOT-CA-20-044 | 05/08/2023 | Richard Mazurchuk, Ph.D | |
| Notice of Special Interest: Small Business Development of Wearable Smart Devices for Continuous Monitoring of Circulating Nutrients, Metabolites and Hormones | NOT-DK-20-002 | 01/08/2023 | ||
| Notice of Special Interest to Encourage Eligible NIH HEAL Initiative Awardees to Apply for PA-20-222: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) | NOT-NS-20-107 | 05/16/2024 | Alexis Bakos, Ph.D., M.P.H., R.N. | |
| Pancreatic Cancer Detection Consortium: Research Units | PAR-21-334 (U01 Clinical Trial Optional) | 06/12/2024 | U01 | Sharmistha Ghosh-Janjigian, Ph.D. |
| Patient-Clinician Relationship: Improving Health Outcomes in Populations that Experience Health Care Disparities | PAR-22-064 (R01 Clinical Trial Optional) | 01/08/2025 | R01 | Diane St Germain, R.N., M.S., C.R.N.P. |
| Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection | PAR-20-053 (R01 Clinical Trial Not Allowed) | 01/08/2023 | R01 | Matthew Young, Ph.D. |
| Promoting Research on Music and Health: Phased Innovation Award for Music Interventions | PAR-20-266 (R61/R33 Clinical Trial Optional) | 06/20/2023 | R33, R61 | Alexis Bakos, Ph.D., M.P.H., R.N. |
| Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants | PAR-20-074 (R01 Clinical Trial Not Allowed) | 10/29/2022 | R01 | Asad Umar, D.V.M., Ph.D. |
| Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes | PAR-20-276 (R01 Clinical Trial Not Allowed) | 01/08/2023 | R01 | Wendy Wang, Ph.D., M.Sc. |
| Stephen I. Katz Early Stage Investigator Research Project Grant | PAR-21-039 (R01 Basic Experimental Studies with Humans Required) | 12/29/2023 | R01 | |
| Stephen I. Katz Early Stage Investigator Research Project Grant | PAR-21-038 (R01 Clinical Trial Not Allowed) | 12/29/2023 | R01 | |
| Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research | PAR-21-330 (U01 Clinical Trial Not Allowed) | 10/12/2024 | U01 | Claire Zhu, Ph.D. |